Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity

NCT02798679 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02798679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02798679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity
Lead sponsor
University of Minnesota
Phase
Observational
Overall status
Completed
Start date
August 31, 2016
Completion date
September 1, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity